Published in US Oncol Hematol on January 01, 2011
POWS: Palonosetron/Ondansetron Opioid Withdrawal Study | NCT00661674
Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother (2013) 0.90
Anticipatory nausea in animal models: a review of potential novel therapeutic treatments. Exp Brain Res (2014) 0.78
Hypnosis for the Management of Anticipatory Nausea and Vomiting. J Adv Pract Oncol (2015) 0.75
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30. Eur J Nucl Med Mol Imaging (2017) 0.75
Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2011) 7.24
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96
Chemotherapy-induced nausea and vomiting. N Engl J Med (2008) 4.00
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol (2009) 3.69
The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull (2004) 3.45
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol (2005) 2.86
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol (2006) 2.84
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg (2008) 2.79
Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther (2004) 2.48
Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain--preliminary experience. Radiology (1999) 2.23
Ginger root--a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynaecological surgery. Anaesthesia (1990) 2.18
Cancer preventive properties of ginger: a brief review. Food Chem Toxicol (2006) 2.18
Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol (1991) 2.06
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function. Eur J Pharmacol (2009) 1.81
Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76
Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J Pharmacol Exp Ther (2008) 1.73
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. J Clin Oncol (2003) 1.68
The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol (1995) 1.57
Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl) (2007) 1.53
The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo. J Pharmacol Exp Ther (2010) 1.48
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy. Cancer (2005) 1.37
Zingiber officinale (ginger)--an antiemetic for day case surgery. Anaesthesia (1993) 1.36
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials. Eur J Cancer (2005) 1.36
Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32
Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med (2000) 1.31
Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28
Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant. J Support Oncol (2006) 1.25
Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19
The effect of aerobic exercise on patient reports of nausea. Oncol Nurs Forum (1988) 1.16
The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial. Support Care Cancer (2008) 1.14
The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom Med (1990) 1.13
The role of cognition in classical and operant conditioning. J Clin Psychol (2004) 1.12
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology (1996) 1.12
Chinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients. Cochrane Database Syst Rev (2007) 1.10
Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09
Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting. Core Evid (2010) 1.09
Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea. Ann Behav Med (1998) 1.06
Development of anticipatory nausea: a prospective analysis. J Consult Clin Psychol (1985) 1.05
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial. Support Care Cancer (2001) 1.05
Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. J Consult Clin Psychol (1987) 1.04
Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy. Oncology (2000) 1.02
Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.01
Anti-emetic therapy in cancer chemotherapy: current status. Basic Clin Pharmacol Toxicol (2007) 1.00
Motion sickness, ginger, and psychophysics. Lancet (1982) 1.00
The efficacy of ginger root in the prevention of postoperative nausea and vomiting after outpatient gynaecological laparoscopy. Anaesthesia (1998) 1.00
Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer (1998) 0.99
Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage (2000) 0.99
Relationships between patients' pre-treatment expectations of toxicities and post chemotherapy experiences. Psychooncology (2005) 0.98
The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage (2001) 0.98
Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med (1993) 0.97
Massage relieves nausea in women with breast cancer who are undergoing chemotherapy. J Altern Complement Med (2007) 0.97
Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments. Drugs (2009) 0.96
Anticipatory nausea and/or vomiting. Cancer Treat Rev (1984) 0.95
Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial. Oncol Nurs Forum (2007) 0.95
Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol (1984) 0.95
Specific response expectancies predict anticipatory nausea during chemotherapy for breast cancer. J Consult Clin Psychol (2001) 0.95
Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol (1991) 0.94
A progress study of 100 cancer patients treated by acupressure for chemotherapy-induced vomiting after failure with the pharmacological approach. Minerva Med (2007) 0.94
Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer. Cancer (1988) 0.94
Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy. J Consult Clin Psychol (1982) 0.93
Effects of overshadowing on conditioned nausea in cancer patients: an experimental study. Physiol Behav (1998) 0.92
Anticipatory nausea and vomiting. Support Care Cancer (2004) 0.91
Exposure to a context previously associated with nausea elicits conditioned gaping in rats: a model of anticipatory nausea. Behav Brain Res (2007) 0.91
Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy. Support Care Cancer (2010) 0.91
An exploratory study on the effects of an expectancy manipulation on chemotherapy-related nausea. J Pain Symptom Manage (2010) 0.90
Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity. Ann Behav Med (2007) 0.90
A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting. Anaesth Intensive Care (1995) 0.90
Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. J Dev Behav Pediatr (1994) 0.90
Patient expectancy and post-chemotherapy nausea: a meta-analysis. Ann Behav Med (2010) 0.89
How do patient expectancies, quality of life, and postchemotherapy nausea interrelate? Cancer (2008) 0.89
Variables associated with anticipatory nausea and vomiting in pediatric cancer patients receiving ondansetron antiemetic therapy. J Pediatr Psychol (1997) 0.89
Anticipatory nausea among ambulatory cancer patients undergoing chemotherapy: prevalence, associated factors, and impact on quality of life. Cancer Sci (2010) 0.89
Biobehavioral factors in chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw (2004) 0.88
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer. Future Oncol (2010) 0.88
Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy? Oncology (Williston Park) (2007) 0.87
The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning. Auton Neurosci (2006) 0.87
Ginger root against seasickness. A controlled trial on the open sea. Acta Otolaryngol (1988) 0.87
Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Support Care Cancer (2010) 0.87
A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics (1991) 0.86
The effects of family support, anxiety, and post-treatment nausea on the development of anticipatory nausea: a latent growth model. J Pain Symptom Manage (2007) 0.86
New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron. Expert Opin Drug Metab Toxicol (2005) 0.86
Effectiveness of biofeedback and relaxation training in reducing the side effects of cancer chemotherapy. Health Psychol (1992) 0.85
Antiemesis. Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2009) 0.84
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only). Support Care Cancer (2010) 0.83
Acute emesis: moderately emetogenic chemotherapy. Support Care Cancer (2010) 0.83
Changes in family relationships affect the development of chemotherapy-related nausea symptoms. Support Care Cancer (2003) 0.83
A pilot study of the use of progressive muscle relaxation training in the management of post-chemotherapy nausea and vomiting. Eur J Cancer Care (Engl) (2000) 0.83
Anticipatory nausea and emesis, and psychological morbidity: assessment of prevalence among out-patients on mild to moderate chemotherapy regimens. Br J Cancer (1992) 0.81
The development and management of chemotherapy-related anticipatory nausea and vomiting. Cancer Invest (1988) 0.81
Role of classical conditioning in learning gastrointestinal symptoms. World J Gastroenterol (2007) 0.81
Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol (1992) 0.80
Behavioral treatment of chemotherapy-induced nausea and vomiting. Oncology (Williston Park) (1993) 0.80
Controlling emesis: evolving challenges, novel strategies. J Support Oncol (2010) 0.78
Progress in reducing anticipatory nausea and vomiting: a study of community practice. Support Care Cancer (1998) 0.78
The influence of guided imagery on chemotherapy-related nausea and vomiting. Oncol Nurs Forum (1993) 0.77